D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 73 Citations 18,126 488 World Ranking 15816 National Ranking 595

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Chemotherapy

Alfredo Berruti spends much of his time researching Internal medicine, Oncology, Surgery, Adrenocortical carcinoma and Endocrinology. Many of his studies on Internal medicine apply to Gastroenterology as well. His studies deal with areas such as Epirubicin, Cyclophosphamide, Immunology, Systemic therapy and Vitamin D and neurology as well as Oncology.

His Adrenocortical carcinoma study incorporates themes from Adrenal Cortex Carcinoma, Phases of clinical research, Retrospective cohort study, Stage and Adjuvant therapy. His study in Endocrinology is interdisciplinary in nature, drawing from both Androgen deprivation therapy and Prostate cancer. His Chemotherapy research includes themes of Regimen and Pharmacology.

His most cited work include:

  • Adjuvant mitotane treatment for adrenocortical carcinoma. (516 citations)
  • Prevalence of adrenal incidentaloma in a contemporary computerized tomography series (444 citations)
  • Changes in Bone Mineral Density, Lean Body Mass and Fat Content as Measured by Dual Energy X-Ray Absorptiometry in Patients With Prostate Cancer Without Apparent Bone Metastases Given Androgen Deprivation Therapy (265 citations)

What are the main themes of his work throughout his whole career to date?

Alfredo Berruti focuses on Internal medicine, Oncology, Chemotherapy, Prostate cancer and Breast cancer. His Internal medicine research incorporates themes from Gastroenterology, Endocrinology and Surgery. His Oncology research includes elements of Cyclophosphamide, Disease, Retrospective cohort study and Hazard ratio.

His research on Chemotherapy often connects related topics like Regimen. Alfredo Berruti combines subjects such as Prostate, Chromogranin A and Urology with his study of Prostate cancer. Alfredo Berruti studies Mitotane which is a part of Adrenocortical carcinoma.

He most often published in these fields:

  • Internal medicine (73.92%)
  • Oncology (45.80%)
  • Chemotherapy (19.73%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (73.92%)
  • Oncology (45.80%)
  • Adrenocortical carcinoma (13.83%)

In recent papers he was focusing on the following fields of study:

Internal medicine, Oncology, Adrenocortical carcinoma, Prostate cancer and Mitotane are his primary areas of study. In his study, Immunohistochemistry is strongly linked to Endocrinology, which falls under the umbrella field of Internal medicine. His research integrates issues of Nivolumab, Adverse effect, Proportional hazards model and Hazard ratio in his study of Oncology.

His Adrenocortical carcinoma study combines topics from a wide range of disciplines, such as Cancer research, Randomized controlled trial, Surgery, Molecular biology and Rare disease. His work deals with themes such as Bone health and Docetaxel, which intersect with Prostate cancer. As a part of the same scientific family, Alfredo Berruti mostly works in the field of Mitotane, focusing on Adjuvant and, on occasion, Radical surgery.

Between 2018 and 2021, his most popular works were:

  • Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. (90 citations)
  • Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (54 citations)
  • Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme. (39 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Chemotherapy

Alfredo Berruti mostly deals with Internal medicine, Oncology, Clinical Practice, Chemotherapy and Hazard ratio. His research in Internal medicine intersects with topics in Endocrinology and Perioperative. His work on Mitotane as part of general Endocrinology research is often related to Context, thus linking different fields of science.

His Oncology research is multidisciplinary, incorporating elements of Cancer, Breast cancer, Prostate cancer, Meta-analysis and Recurrent glioblastoma. His work carried out in the field of Chemotherapy brings together such families of science as Lesion, Neuroradiology, Group B, Colorectal cancer and Survival analysis. His Hazard ratio study integrates concerns from other disciplines, such as Proportional hazards model and Retrospective cohort study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Adjuvant mitotane treatment for adrenocortical carcinoma.

Massimo Terzolo;Alberto Angeli;Martin Fassnacht;Fulvia Daffara.
The New England Journal of Medicine (2007)

811 Citations

Prevalence of adrenal incidentaloma in a contemporary computerized tomography series

S. Bovio;A. Cataldi;G. Reimondo;P. Sperone.
Journal of Endocrinological Investigation (2006)

742 Citations

Combination Chemotherapy in Advanced Adrenocortical Carcinoma

Martin Fassnacht;Massimo Terzolo;Bruno Allolio;Eric Baudin.
The New England Journal of Medicine (2012)

739 Citations

European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors

Martin Fassnacht;Olaf M. Dekkers;Olaf M. Dekkers;Tobias Else;Eric Baudin;Eric Baudin.
European Journal of Endocrinology (2018)

492 Citations

Changes in Bone Mineral Density, Lean Body Mass and Fat Content as Measured by Dual Energy X-Ray Absorptiometry in Patients With Prostate Cancer Without Apparent Bone Metastases Given Androgen Deprivation Therapy

Alfredo Berruti;Luigi Dogliotti;Carlo Terrone;Stefania Cerutti.
The Journal of Urology (2002)

403 Citations

Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

A. Berruti;E. Baudin;H. Gelderblom;H. R. Haak.
Annals of Oncology (2012)

395 Citations

Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.

S Filetti;C Durante;D Hartl;D Hartl;S Leboulleux;S Leboulleux.
Annals of Oncology (2019)

380 Citations

Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial.

Alfredo Berruti;Massimo Terzolo;Paola Sperone;Anna Pia.
Endocrine-related Cancer (2005)

340 Citations

Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Marianne Pavel;Kjell Öberg;Massimo Falconi;Eric Krenning.
Annals of Oncology (2020)

336 Citations

Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer.

Daniele Generali;Alfredo Berruti;Maria P Brizzi;Leticia Campo.
Clinical Cancer Research (2006)

302 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Alfredo Berruti

Martin Fassnacht

Martin Fassnacht

University of Würzburg

Publications: 111

Matthew R. Smith

Matthew R. Smith

Harvard University

Publications: 62

Massimo Terzolo

Massimo Terzolo

University of Turin

Publications: 54

Eric Baudin

Eric Baudin

Institut Gustave Roussy

Publications: 49

Fred Saad

Fred Saad

University of Montreal

Publications: 48

Mauro Papotti

Mauro Papotti

University of Turin

Publications: 46

Jérôme Bertherat

Jérôme Bertherat

Université Paris Cité

Publications: 43

Felix Beuschlein

Felix Beuschlein

University of Zurich

Publications: 42

Daniele Santini

Daniele Santini

Università Campus Bio-Medico

Publications: 41

Gregory Kaltsas

Gregory Kaltsas

National and Kapodistrian University of Athens

Publications: 36

Bruno Allolio

Bruno Allolio

University of Würzburg

Publications: 34

Shahrokh F. Shariat

Shahrokh F. Shariat

Medical University of Vienna

Publications: 31

adrian l harris

adrian l harris

University of Oxford

Publications: 28

Hironobu Sasano

Hironobu Sasano

Tohoku University

Publications: 27

Marcus Quinkler

Marcus Quinkler

Charité - University Medicine Berlin

Publications: 27

Annamaria Colao

Annamaria Colao

University of Naples Federico II

Publications: 27

Something went wrong. Please try again later.